TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > Our Services > Tech Transfer / Scale-up

Tech Transfer / Scale-up

Confidence Beyond Compliance

Pharmaceutical batch sizes manufactured to support the NDA or ANDA license application are typically scaled up to larger batch sizes after approval.

FDA Scale-up and Post Approval Changes (SUPAC) guidance provides recommendations to product license holders on scale-up of the process and making a change to the site of manufacture or testing post NDA or ANDA approval. Scale-up activities should be managed under the Pharmaceutical Quality System (ICH Q10).

Also, current regulations and FDA Technology Transfer best practice standards demand that any transfer of a technology as required to support SUPAC to the CMC documentation, is managed under the Pharmaceutical Quality System.

PharmaLex’s team of experts, which includes a number of former EU regulators, have the experience and expertise to provide support services to your scale-up operations, including:

  • Working with Technical Services, Validation, Manufacturing Operations and Regulatory to
    • identify changes to the manufacturing process, equipment, or site of manufacturing or testing to scale-up the batch size
    • assess the changes required as Major, Moderate or Minor, in accordance with regulatory guidance
    • advise on regulatory filing procedures based on the category of the changes, i.e. For US, Prior Approval supplement, Changes Being Affected supplement or Annual reportable; for EU Type 1 or Type 2 variation
    • advise your SMEs on validations and/or release testing to be performed in order to confirm successful scale-up (or down) of batch size, and any Technical Transfer activities employed as part of the scale-up process.
  • Providing guidance and support on preparation of scale-up documentation, including protocols which
    • define the scale-up activities
    • assign roles and responsibilities
    • document performance of validations and/or release testing to confirm successful scale-up (or down) of batch size, and any Technology Transfer activities employed as part of the scale-up process
    • apply Risk Management principles to the scale-up operation
    • describe performing the scale-up under the management of the Pharmaceutical Quality System, including management of documentation, change control, deviation investigations and CAPA management
    • require appropriate sign off/approval by relevant parties and by Quality on completion of the scale-up protocol
    • and scale-up reports, including associated records of actions taken or conclusions reached as part of the Scale-up activities
  • Providing support in the management of scale-up projects, whether within-site or inter-site, and incorporating Technology Transfer activities, to
    • ensure that the key milestones of the project are identified
    • ensure that the challenges to the scale-up process are identified
    • ensure the application of Quality Risk Management to the process
    • ensure that the scale-up process is completed effectively, efficiently and meets regulatory expectations and compliance.

Providing training on scale-up activities in compliance with GMP and regulatory guidance.

Related News

PharmaLex expands technology-enabled solution portfolio with integration of software platforms
PharmaLex expands technology-enabled solution portfolio with integration of software platforms
30th November 2021
Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm
Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm
13th October 2021
PharmaLex expands IT consulting and system integration expertise for the Life Science industry
PharmaLex expands IT consulting and system integration expertise for the Life Science industry
14th September 2021

Related Resources

Thought Leadership

  • Together Beyond COVID-19 - A Look to the Future
  • EPR - the regulatory intelligence the platform deserves
  • AI in drug development|Pharmacovigilance
  • Digitally Transforming Pharma’s Regulatory Processes
  • AI in drug development: Regulatory Affairs - Part 1: Regulatory Affairs
  • Moving From Artificial Trials To Smarter Regulatory Process
  • The 5 things you want to know about Artificial Intelligence

Fact Flyers

  • SMARTVIGISCREEN - Flyer

White Papers

  • Software, AI and Medical Devices - What's Up?

Webinars

  • EudraVigilance – The fundamental tool for Pharmacovigilance

Video & Animation

  • Using Technology-enabled Smart Services - what are the benefits?
  • SMARTPHLEX - Technology-enabled Smart Solutions
  • SMARTRISK - What is SMARTRISK

Related Services

  • Computer System Validation (CSV)
  • Digital Health Teaser Tool
  • Global Procedure Management
  • GxP Services
  • Interim / Contract QA
  • Literature Monitoring & Screening
  • Regulatory Operations
  • SMART MDR Teaser Tool
  • SMARTAUTOMATE
  • SMARTCHECK
  • SMARTCHECK MDR
  • SMARTCHECK-MDR
  • SMARTDECISIONS
  • SMARTENOVAL – analytical method validation software
  • SMARTPHLEX
  • SMARTRISK
  • SMARTSEELVA – bioassay validation software
  • SMARTSTABELITY – product stability and shelf-life estimation software
  • SMARTTRACE
  • SMARTTRANSVAL – analytical method transfer software
  • SMARTVIGICONTRACT
  • SMARTVIGILIT
  • SMARTVIGISCREEN
  • Statistics and Data Sciences
  • Technology Enabled Services

What our clients say

During the bid defense we felt that you worked well as team and are very dynamic. Preparation of such a complex dossier really needs to be done in such a way.

Large Pharma, Germany
VP Regulatory Affairs

They are available when we need to talk to them despite any time zone differentials

Japan based medium sized company
Manager

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
4 May

Francesco Lanucara’s latest article discusses how important it is to provide clear information and keep up with regulatory guidelines.

Read the article here: https://lnkd.in/dFt4KBVy

For this and more articles subscribe to our newsletter.
#cellandgene #lifescience #cmc #ilap

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • During the bid defense we felt that you worked well as team and are very dynamic. Preparation of such a complex dossier really needs to be done in such a way.

    Large Pharma, Germany
    VP Regulatory Affairs
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for